395.20
+4.40
+(1.13%)
As of 11:04:58 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 14 | 18 | 18 |
| Avg. Estimate | 1.32B | 1.27B | 4.96B | 5.37B |
| Low Estimate | 1.31B | 1.24B | 4.95B | 5.2B |
| High Estimate | 1.34B | 1.31B | 4.99B | 5.56B |
| Year Ago Sales | 1.01B | 1.18B | 4.58B | 4.96B |
| Sales Growth (year/est) | 30.49% | 8.22% | 8.30% | 8.22% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZT1A.F | -- | -- | -- | -- |
| S&P 500 | 9.38% | 11.28% | 14.02% | 13.55% |
Upgrades & Downgrades
| Maintains | Truist Securities: Hold to Hold | 1/16/2025 |
| Initiated | Citigroup: Neutral | 1/14/2025 |
| Maintains | Truist Securities: Hold to Hold | 12/19/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/17/2024 |
| Upgrade | Morgan Stanley: Underweight to Equal-Weight | 12/2/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 10/31/2024 |